NWK Group Inc. Acquires Shares of 17,975 Celestica, Inc. $CLS

Key Points

• NWK Group Inc. opened a new position in Celestica during the fourth quarter, buying 17,975 shares valued at about $5.31 million. The stake represents roughly 1.8% of NWK’s portfolio and is its 22nd largest holding.
• Celestica continues to attract favorable analyst sentiment, with a consensus rating of Moderate Buy and an average target price of $427.42. Several firms also recently raised price targets, reflecting optimism around the stock.
• The company reported strong quarterly results, including EPS of $2.16 versus estimates of $2.08 and revenue growth of 52.8% year over year. Despite that momentum, the shares trade at a premium and insider Director Michael Max Wilson recently sold shares in a tax-related transaction.

NWK Group Inc. bought a new position in Celestica, Inc. (NYSE:CLS - Free Report) TSE: CLS in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 17,975 shares of the technology company's stock, valued at approximately $5,314,000. Celestica makes up approximately 1.8% of NWK Group Inc.'s investment portfolio, making the stock its 22nd largest holding.

A number of other institutional investors and hedge funds have also modified their holdings of CLS. NewGen Equity Long Short Fund bought a new stake in shares of Celestica in the 2nd quarter worth $14,050,000. Northwestern Mutual Wealth Management Co. increased its holdings in shares of Celestica by 7,646.2% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 1,007 shares of the technology company's stock worth $157,000 after purchasing an additional 994 shares in the last quarter. First Trust Advisors LP increased its holdings in shares of Celestica by 30.0% in the 2nd quarter. First Trust Advisors LP now owns 78,061 shares of the technology company's stock worth $12,197,000 after purchasing an additional 18,025 shares in the last quarter. NewEdge Advisors LLC increased its holdings in shares of Celestica by 385.8% in the 2nd quarter. NewEdge Advisors LLC now owns 2,803 shares of the technology company's stock worth $438,000 after purchasing an additional 2,226 shares in the last quarter. Finally, HUB Investment Partners LLC increased its holdings in shares of Celestica by 11.0% in the 2nd quarter. HUB Investment Partners LLC now owns 3,181 shares of the technology company's stock worth $497,000 after purchasing an additional 315 shares in the last quarter. Institutional investors own 67.38% of the company's stock.

Key Celestica News

Here are the key news stories impacting Celestica this week:

• Positive Sentiment: Several articles highlighted that Celestica continues to screen well on growth-focused metrics, with Zacks calling it a “strong growth stock” and another note pointing to strong interest coverage, suggesting solid earnings quality and balance-sheet resilience. Article: Here's Why Celestica (CLS) is a Strong Growth Stock
• Positive Sentiment: Analyst coverage remains favorable, with reports saying Celestica carries an average rating of “Moderate Buy” and that Wall Street bulls remain optimistic about the stock. Article: Celestica, Inc. NYSE: CLS Given Average Rating of "Moderate Buy" by Analysts
• Neutral Sentiment: Market commentary focused on what comes next after last month’s earnings report, with articles noting the stock has already gained since results and that investors are looking for clues in future earnings estimates rather than reacting to a new announcement. Article: Why Is Celestica (CLS) Up 2.6% Since Last Earnings Report?
• Neutral Sentiment: A separate valuation-focused note said Celestica’s share price is far above GuruFocus’s GF Value estimate, reinforcing that the stock may be trading at a premium and could be vulnerable to pullbacks after its strong advance. Article: A Look at Celestica Inc (CLS) After 3.5% Decline -- GF Value $125.81 vs Price $357.70

Insider Transactions at Celestica

In other Celestica news, Director Michael Max Wilson sold 4,168 shares of the business's stock in a transaction dated Tuesday, May 19th. The stock was sold at an average price of $333.31, for a total transaction of $1,389,236.08. Following the completion of the sale, the director owned 24,718 shares of the company's stock, valued at approximately $8,238,756.58. The trade was a 14.43% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Corporate insiders own 1.10% of the company's stock.

Celestica Stock Performance

Shares of CLS opened at $356.77 on Thursday. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.26 and a quick ratio of 0.73. Celestica, Inc. has a one year low of $110.54 and a one year high of $435.00. The firm has a market capitalization of $41.02 billion, a P/E ratio of 43.14, a PEG ratio of 0.86 and a beta of 2.09. The business has a fifty day moving average of $347.02 and a 200 day moving average of $317.29.

Celestica (NYSE:CLS - Get Free Report) TSE: CLS last issued its quarterly earnings data on Monday, April 27th. The technology company reported $2.16 EPS for the quarter, topping the consensus estimate of $2.08 by $0.08. Celestica had a return on equity of 36.91% and a net margin of 6.95%.The company had revenue of $3.96 billion during the quarter, compared to analyst estimates of $3.97 billion. During the same quarter in the previous year, the company posted $1.20 earnings per share. Celestica's revenue was up 52.8% compared to the same quarter last year. Celestica has set its FY 2026 guidance at 10.150-10.150 EPS and its Q2 2026 guidance at 2.140-2.340 EPS. As a group, sell-side analysts anticipate that Celestica, Inc. will post 9.5 EPS for the current year.

Analyst Ratings Changes

A number of research firms have commented on CLS. TD lifted their target price on Celestica from $330.00 to $350.00 and gave the stock a "hold" rating in a report on Monday, April 20th. Weiss Ratings raised Celestica from a "buy (b-)" rating to a "buy (b)" rating in a report on Monday, May 4th. Canaccord Genuity Group lifted their target price on Celestica from $400.00 to $430.00 and gave the stock a "buy" rating in a report on Monday, February 2nd. Susquehanna lifted their target price on Celestica from $460.00 to $510.00 and gave the stock a "positive" rating in a report on Wednesday, April 29th. Finally, Royal Bank Of Canada lifted their target price on Celestica from $400.00 to $440.00 and gave the stock an "outperform" rating in a report on Wednesday, April 29th. One research analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating and three have given a Hold rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $427.42.

Celestica Company Profile

Celestica Inc is a multinational electronics manufacturing services (EMS) company that provides design, engineering, manufacturing and supply chain solutions to original equipment manufacturers across a range of industries. Headquartered in Toronto, Ontario, Canada, Celestica works with customers to develop and produce complex electronic and electro-mechanical products, integrating activities from product design and prototyping through high-volume assembly, testing and final system integration.

The company's service offering typically includes product engineering and design support, printed circuit board assembly, box-build and systems assembly, automated test and inspection, aftermarket repair and refurbishment, and end-to-end supply chain and logistics management.

Want to see what other hedge funds are holding CLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Celestica, Inc. (NYSE:CLS - Free Report) TSE: CLS.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.